Armata Pharmaceuticals, Inc. (ARMP) › Capital ExpendituresArmata Pharmaceuticals, Inc. (ARMP) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2013: $102.0K2014: $1.20M2015: $210.0K2016: $279.0K2017: $58.0K2018: $875.0K2019: $224.0K2020: $824.0K2021: $1.30M2022: $2.21M2023: $8.14M2024: $1.88M2025: $542.0K$542.0K2013Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$542.0K-71.2%2024$1.88M-76.9%2023$8.14M+268.3%2022$2.21M+69.6%2021$1.30M+58.3%2020$824.0K+267.9%2019$224.0K-74.4%2018$875.0K+1408.6%2017$58.0K-79.2%2016$279.0K+32.9%2015$210.0K-82.5%2014$1.20M+1078.4%2013$102.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share